On June 1st, Tencent’s health unit secured Class III approval from China’s National Medical Products Administration (NMPA) for its AI-powered diagnostic software for colonic polyps. The product is specifically designed for detecting adult colonic polyps and is capable of identifying and displaying suspected polyp regions within video images captured by electronic endoscopes. This product is the third AI-assisted diagnostic software for intestinal polyps to obtain NMPA approval, out of a total of 208 innovative medical devices across all fields. The previous two software approvals were granted to Chengdu Weishi Medical Devices in August 2022, and Wuhan Chujingling in May 2023. [Caixin, in Chinese]